GB201707189D0 - Novel formulations - Google Patents
Novel formulationsInfo
- Publication number
- GB201707189D0 GB201707189D0 GBGB1707189.5A GB201707189A GB201707189D0 GB 201707189 D0 GB201707189 D0 GB 201707189D0 GB 201707189 A GB201707189 A GB 201707189A GB 201707189 D0 GB201707189 D0 GB 201707189D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel formulations
- formulations
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1707189.5A GB201707189D0 (en) | 2017-05-05 | 2017-05-05 | Novel formulations |
| EP18723925.6A EP3618840B1 (en) | 2017-05-05 | 2018-05-03 | Stable insulin formulations |
| ES18723925T ES2973374T3 (en) | 2017-05-05 | 2018-05-03 | Stable insulin formulations |
| PCT/GB2018/051177 WO2018203059A1 (en) | 2017-05-05 | 2018-05-03 | Stable insulin formulations |
| US16/610,826 US20200093895A1 (en) | 2017-05-05 | 2018-05-03 | Stable insulin formulations |
| CN201880029060.2A CN110582285B (en) | 2017-05-05 | 2018-05-03 | stable insulin preparations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1707189.5A GB201707189D0 (en) | 2017-05-05 | 2017-05-05 | Novel formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201707189D0 true GB201707189D0 (en) | 2017-06-21 |
Family
ID=59065456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1707189.5A Ceased GB201707189D0 (en) | 2017-05-05 | 2017-05-05 | Novel formulations |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20200093895A1 (en) |
| EP (1) | EP3618840B1 (en) |
| CN (1) | CN110582285B (en) |
| ES (1) | ES2973374T3 (en) |
| GB (1) | GB201707189D0 (en) |
| WO (1) | WO2018203059A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201607918D0 (en) | 2016-05-06 | 2016-06-22 | Arecor Ltd | Novel formulations |
| IL265609B2 (en) | 2016-09-29 | 2024-02-01 | Arecor Ltd | Aqueous liquid pharmaceutical formulation comprising insulin, ionic zinc, non-ionic surfactant and a medical device comprising the formulation |
| IL270975B2 (en) | 2017-06-01 | 2024-02-01 | Lilly Co Eli | Rapid-acting insulin compositions |
| EP3773473A1 (en) * | 2018-04-04 | 2021-02-17 | Arecor Limited | Medical infusion pump system for the delivery of an insulin compound |
| WO2019193353A1 (en) * | 2018-04-04 | 2019-10-10 | Arecor Limited | Medical infusion pump system for the delivery of an insulin compound |
| IL277731B2 (en) * | 2018-04-04 | 2024-03-01 | Arecor Ltd | A medical infusion pump system for administration of an insulin compound |
| GB202004814D0 (en) | 2020-04-01 | 2020-05-13 | Arecor Ltd | Novel formulations |
| CN118924882A (en) * | 2023-05-10 | 2024-11-12 | 上海仁会生物制药股份有限公司 | Pharmaceutical composition and use thereof, method for improving storage stability of pharmaceutical composition |
| CN119405787A (en) * | 2024-09-24 | 2025-02-11 | 广东东阳光生物制剂有限公司 | A high-stability, high-concentration zinc-containing insulin preparation |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| JPH04502465A (en) | 1988-12-23 | 1992-05-07 | ノボ ノルディスク アクティーゼルスカブ | human insulin analogue |
| IL93282A (en) | 1989-02-09 | 1995-08-31 | Lilly Co Eli | Insulin analogs |
| DE69019534T2 (en) | 1989-12-21 | 1995-09-21 | Novonordisk As | INSULIN PREPARATIONS CONTAINING NICOTIC ACID OR NICOTINAMIDE. |
| US5866538A (en) | 1996-06-20 | 1999-02-02 | Novo Nordisk A/S | Insulin preparations containing NaCl |
| DE10114178A1 (en) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinc-free and low-zinc insulin preparations with improved stability |
| US8084420B2 (en) * | 2005-09-29 | 2011-12-27 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
| US8084022B2 (en) | 2006-06-23 | 2011-12-27 | Aegis Therapeutics, Llc | Stabilizing alkylglycoside compositions and methods thereof |
| GB0700523D0 (en) | 2007-01-11 | 2007-02-21 | Insense Ltd | The Stabilisation Of Proteins |
| WO2008152106A1 (en) * | 2007-06-13 | 2008-12-18 | Novo Nordisk A/S | Pharmaceutical formulation comprising an insulin derivative |
| US9060927B2 (en) * | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake |
| KR101775000B1 (en) | 2009-06-26 | 2017-09-04 | 노보 노르디스크 에이/에스 | Preparation comprising insulin, nicotinamide and an amino acid |
| EP2590667A4 (en) | 2010-07-07 | 2013-11-27 | Biodel Inc | COMPOSITIONS AND METHODS FOR THE MODULATION OF PHARMACOKINETICS AND PHARMACODYNAMIC INSULIN |
| US20130231281A1 (en) | 2011-11-02 | 2013-09-05 | Adocia | Rapid acting insulin formulation comprising an oligosaccharide |
| BR112014025132A2 (en) * | 2012-04-11 | 2017-07-11 | Novo Nordisk As | insulin formulations |
| US9381247B2 (en) * | 2012-04-16 | 2016-07-05 | Biodel Inc. | Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain |
| JP6322642B2 (en) * | 2012-11-13 | 2018-05-09 | アドシア | Fast-acting insulin preparation containing a substituted anionic compound |
| CA2889165A1 (en) * | 2012-12-19 | 2014-06-26 | Wockhardt Limited | A stable aqueous composition comprising human insulin or an analogue or derivative thereof |
| BR112016016290A2 (en) * | 2014-01-13 | 2017-10-03 | Thermalin Diabetes Llc | PHARMACEUTICAL COMPOSITIONS OF FAST-ACTING INSULIN, INFUSION SET, INFUSION SET SYSTEM AND USES OF MONOMER OR DIMERIC INSULIN ANALOGS |
| US20150273022A1 (en) | 2014-02-10 | 2015-10-01 | Biodel Inc. | Stabilized ultra-rapid-acting insulin formulations |
| TWI685348B (en) | 2014-05-08 | 2020-02-21 | 美國禮來大藥廠 | Rapid-acting insulin compositions |
| GB201607918D0 (en) * | 2016-05-06 | 2016-06-22 | Arecor Ltd | Novel formulations |
-
2017
- 2017-05-05 GB GBGB1707189.5A patent/GB201707189D0/en not_active Ceased
-
2018
- 2018-05-03 CN CN201880029060.2A patent/CN110582285B/en active Active
- 2018-05-03 ES ES18723925T patent/ES2973374T3/en active Active
- 2018-05-03 WO PCT/GB2018/051177 patent/WO2018203059A1/en not_active Ceased
- 2018-05-03 US US16/610,826 patent/US20200093895A1/en active Pending
- 2018-05-03 EP EP18723925.6A patent/EP3618840B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018203059A1 (en) | 2018-11-08 |
| EP3618840B1 (en) | 2023-12-27 |
| US20200093895A1 (en) | 2020-03-26 |
| CN110582285B (en) | 2023-04-14 |
| CN110582285A (en) | 2019-12-17 |
| EP3618840C0 (en) | 2023-12-27 |
| EP3618840A1 (en) | 2020-03-11 |
| ES2973374T3 (en) | 2024-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273541A (en) | Formulations | |
| IL273282A (en) | Niraparib formulations | |
| IL269630A (en) | Niraparib formulations | |
| IL269621A (en) | Niraparib formulations | |
| IL265609A (en) | Novel formulations | |
| GB2600652B (en) | Novel compositions | |
| GB201607918D0 (en) | Novel formulations | |
| GB201707189D0 (en) | Novel formulations | |
| EP3373928A4 (en) | Novel formulations | |
| GB201809976D0 (en) | Novel formulations | |
| GB201701239D0 (en) | Novel formulation | |
| GB201707188D0 (en) | Novel formulations | |
| GB201718470D0 (en) | Adhesive formulations | |
| GB201707187D0 (en) | Novel formulations | |
| IL254075B (en) | Durable pest-repelling formulations | |
| GB201504482D0 (en) | Novel formulations | |
| IL268195A (en) | Solid fosmetpantothenate formulations | |
| GB201716291D0 (en) | Novel formulations | |
| SG11202011823SA (en) | Activator-nucleator formulations | |
| GB201707562D0 (en) | Novel formulations | |
| GB201707564D0 (en) | Novel formulations | |
| GB201707190D0 (en) | Novel Formulations | |
| GB201714461D0 (en) | Formulations | |
| GB201819028D0 (en) | Butanol-based formulations | |
| GB201808386D0 (en) | Formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |